Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Redeeming credit card points can be tricky. Discover what to avoid to ensure you make the most out of your rewards and benefits.
19,422 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
SEC Chair Atkins rejects calls for immediate market intervention, outlining a rulemaking roadmap for crypto assets an...
A rally in AeroVironment shares has investors wondering what sparked the move. This guide breaks down the factors beh...
Mesirow Financial Investment Management revealed a substantial new holding in the Akre Focus ETF. This piece explains...
Alphabet stock moved higher in a week driven by AI chip ambitions, cloud momentum, and a resilient ad business. This ...
When a high-profile artist steps away for health, the financial ripple is real—not just for the performer, but for sp...
Buffett’s retirement signals a new chapter for Berkshire Hathaway. Discover why move over, apple: berkshire could bec...
Macerich faces a retail landscape that’s evolved in 2025. This deep dive breaks down the factors shaping macerich (ma...
Tariff policy volatility follows a high court ruling, and a new AI platform aims to help firms weather the disruption...
When a CEO puts real money behind his own company’s stock, investors sit up and take notice. This article breaks down...
A private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
Institutional traders are piling into XRP spot buying while the futures market cools, signaling a pivot in market par...